Clinical Trials
- Aging, Heart/Cardiovascular, Brain, Spinal Cord & Nervous System
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults (PREVENTABLE)
- Ages75 years and older
- GenderBoth
- Heart/Cardiovascular
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2)
- Ages35 years - 100 years
- GenderBoth
- Heart/Cardiovascular, Endocrine System
Screening for Cardiac Amyloidosis Using Nuclear Imaging for Minority Populations (SCAN-MP)
- Ages60 years and older
- GenderBoth
- Heart/Cardiovascular
Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
- Ages21 years - 80 years
- GenderBoth
- Heart/Cardiovascular
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
- Lymphoma
A Randomized, Phase IIB, Multicenter, Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in Patients With Relapse or Refractory Peripheral T-cell Lymphoma (PTCL)
- Heart/Cardiovascular
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies (CRETE)
- Ages17 years and younger
- GenderBoth
- Brain and Other Nervous System Cancers
A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine Versus Selumetinib (NSC# 748727) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) Not Associated With BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1)
- Heart/Cardiovascular
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke (ARCADIA)
- Ages45 years and older
- GenderBoth